Key result
Cardiac rehabilitation improved exercise capacity compared with standard care in ICD recipients.
Why the study?
While cardiac rehabilitation is known to improve clinical outcomes in cardiovascular disease, its benefits on functional capacity and safety in patients with implantable cardioverter-defibrillators were not well established.
Does structured cardiac rehabilitation improve peak oxygen uptake (peak VO2) and quality of life without increasing adverse events in adult patients with implantable cardioverter-defibrillators?
Meta-Analysis (n=1,461)
Open-label
Does structured cardiac rehabilitation improve peak oxygen uptake (peak VO2) and quality of life without increasing adverse events in adult patients with implantable cardioverter-defibrillators?
This meta-analysis demonstrates that cardiac rehabilitation in patients with implantable cardioverter-defibrillators significantly improves exercise capacity (peak VO2) and quality of life without increasing the risk of ICD shocks, hospitalizations, or cardiac mortality.
Answers are grounded in this paper and cite their sources.
Supports cardiac rehabilitation referral for ICD recipients; extends benefits from broader CVD populations to this high-risk group.
Background/Objectives: Cardiac rehabilitation (CR) is known to improve clinical outcomes in cardiovascular disease, yet its benefits in patients with implantable cardioverter-defibrillators (ICD) are not well established. This meta-analysis evaluated the impact of CR on functional capacity and safety in ICD recipients. Methods: A systematic search of PubMed, Scopus, and Cochrane Library was performed to identify randomized controlled trials (RCT) involving adults who underwent ICD implantation and were assigned to either CR or standard care. The primary outcome was the change in peak oxygen uptake (peak VO2) from the baseline to the final follow-up. Random-effects models were applied, and subgroup analyses were conducted based on follow-up duration, supervision type, baseline peak VO2, and ischemic vs. non-ischemic etiology. Results: Seven RCTs involving 1461 participants (784 CR; 677 control) met the inclusion criteria. CR was associated with a significant improvement peak VO2 compared with usual care, expressed as the mean difference (MD) in change from the baseline to the last follow-up (MD 2 mL·kg−1·min−1; 95% CI 1.02–2.81; I2 = 65.7%), with consistent effects across all subgroups. Quality of life improved in the CR group (MD 6.46; 95% CI 2.25–10.67; I2 = 0%). A non-significant trend toward increased 6MWT distance was observed. CR did not increase adverse events, including ICD shocks, hospitalizations, or cardiac deaths. Conclusions: CR safely enhances exercise capacity and quality of life in ICD recipients without increasing arrhythmic events or mortality. Larger standardized trials are warranted to optimize CR delivery in this population.
No takes yet. Share an insight, caveat, or question.
Călin et al. (2026) conducted a meta-analysis in Patients with implantable cardioverter-defibrillators (ICD) or CRT-D (n=1,461). Cardiac rehabilitation (CR) vs. Standard care / usual care was evaluated on Change in peak oxygen uptake (peak VO2) from baseline to the end of follow-up (MD 1.9 mL·kg−1·min−1, 95% CI 1.13-2.79). Cardiac rehabilitation improved exercise capacity compared with standard care in ICD recipients.
Synapse has enriched 10 related papers. Consider them for comparative context: